Rebound Pain Following Brachial Plexus Block
Conditions
Interventions
LB:Brachial plexus block was performed using 10 mL (133 mg) of liposomal bupivacaine mixed with 10 mL of normal saline.
R:Brachial plexus block was performed using 0.375% ropivacaine 20ml.
Sponsors
Ganzhou People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Under Brachial Plexus Block for Arthroscopic Shoulder Surgery, age 18–60 years, ASA physical status I–III.
Exclusion criteria
Exclusion criteria: 1. Cognitive or psychiatric dysfunction that is expected to impair compliance with the study protocol; 2. Known allergy to local anesthetics or contraindications to conventional postoperative analgesics; 3. Infection at the nerve block injection site; 4. Preoperative daily opioid use for >2 weeks; 5. Patients with peripheral neuropathy or injury, as well as those with severe renal, hepatic, or cardiovascular diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of postoperative rebound pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of rebound pain;Numeric rating scale;Time to first request for analgesia; total analgesic consumption via PCA pump over 48h postoperativel;incidence of rescue analgesia within 48 hours postoperatively;incidence of adverse events within 48 hours postoperatively; | — |
Countries
China
Contacts
Public ContactYisheng Huang
Ganzhou People's Hospital
Outcome results
None listed